Form 4: Elanco Executive Ellen de Brabander Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Ellen de Brabander, Executive Vice President of Innovation and Regulatory Affairs at Elanco Animal Health Inc, reports changes in her beneficial ownership of company stock.
Summary
- On February 27, 2024, Ellen de Brabander acquired 24,362 shares of Elanco Animal Health Inc. common stock at $0.
- On the same day, she disposed of 12,060 shares at a price of $16.46.
- Following these transactions, her direct ownership is 92,813 shares.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, so the sentiment is neutral.
Industry Context
This filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities.
Key Dates
| Date | Description |
|---|---|
| 02/27/2024 | Date of stock acquisition and disposal. |
| 02/29/2024 | Date of signature on the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.